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Ambrose Cheunga
‹Department of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USAa; Division of Pediatric Infectious Diseases and the
Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles, California, USAb; School of Pharmacy, University of East Anglia, Norwich, United Kingdomc;
Genomic Research Laboratory, University of Geneva Hospitals (HUG), Service of Infectious Diseases, Geneva, Switzerlandd
In Staphylococcus aureus, the low-molecular-weight thiol called bacillithiol (BSH), together with cognate S-transferases, is be-
lieved to be the counterpart to the glutathione system of other organisms. To explore the physiological role of BSH in S. aureus,
we constructed mutants with the deletion of bshA (sa1291), which encodes the glycosyltransferase that catalyzes the first step of
BSH biosynthesis, and fosB (sa2124), which encodes a BSH-S-transferase that confers fosfomycin resistance, in several S. aureus
strains, including clinical isolates. Mutation of fosB or bshA caused a 16- to 60-fold reduction in fosfomycin resistance in these S.
aureus strains. High-pressure liquid chromatography analysis, which quantified thiol extracts, revealed some variability in the
amounts of BSH present across S. aureus strains. Deletion of fosB led to a decrease in BSH levels. The fosB and bshAmutants of
strain COL and a USA300 isolate, upon further characterization, were found to be sensitive to H2O2 and exhibited decreased
NADPH levels compared with those in the isogenic parents. Microarray analyses of COL and the isogenic bshAmutant revealed
increased expression of genes involved in staphyloxanthin synthesis in the bshAmutant relative to that in COL under thiol stress
conditions. However, the bshAmutant of COL demonstrated decreased survival compared to that of the parent in human whole-
blood survival assays; likewise, the naturally BSH-deficient strain SH1000 survived less well than its BSH-producing isogenic
counterpart. Thus, the survival of S. aureus under oxidative stress is facilitated by BSH, possibly via a FosB-mediated mecha-
nism, independently of its capability to produce staphyloxanthin.
Staphylococcus aureus, a leading cause of bacterial infections (1),is normally a commensal organism in healthy individuals that
can become pathogenic. Over the course of infection, the bacte-
rium encounters metabolic and environmental stresses within the
host environment, including reactive oxygen species (ROS) gen-
erated by host neutrophils (2) and macrophages (3). Without an
effective response to the damage caused by oxidative stress, the
bacterium is at risk of accumulating deleterious mutations, dam-
aged proteins (4), or lipid peroxides that may lead to membrane
degradation, lysis, and cell death.
One strategy employed by the bacteria to mitigate the effects of
oxidative stress revolves around the use of low-molecular-weight
(LMW) thiols to maintain the cell’s intracellular reducing envi-
ronment. In many prokaryotes, including Gram-negative rods,
the active LMW thiol is glutathione (GSH), which has been impli-
cated in bacterial responses to oxidative stress (5, 6), antibiotic
resistance (7), and survival during the course of infection (8, 9).
Bacillithiol (BSH), first characterized in 2009, is a LMW thiol
that is an-anomeric glycoside of L-cysteinyl-D-glucosamine con-
jugated to L-malic acid and is produced by some genera of Firmi-
cutes, including S. aureus (10). The first gene of the BSH biosyn-
thetic pathway, bshA, is responsible for conjugating L-malic acid
to UDP-GlcNAc to form N-acetylglucosaminylmalate and is nec-
essary for the synthesis of BSH (11, 12). The next gene, bshB,
encodes an enzyme responsible for deacetylating GlcNAc-Mal,
and the last gene, bshC, codes for a cysteine ligase (11). While
multiple bshB paralogs occur in Bacillus species (11, 12), there is
only one, bshB2, in S. aureus (11). Interestingly, laboratory strains
of S. aureus in the 8325 lineage, such as SH1000 and 8325-4, con-
tain an 8-bp insertion in bshC which renders the protein inactive
and, hence, prevents the synthesis of BSH (13, 14).
The enzyme FosB has been shown to confer resistance to fos-
fomycin in S. aureus (15, 16). In vitro, FosB purified from S. aureus
has been reported to function as a BSH-S-transferase (BST) to
inactivate fosfomycin by opening up the epoxide ring of fosfomy-
cin through the conjugation of BSH to the compound and, hence,
inactivating the drug (17–19). While factors such as importers
(e.g., GlpT [16] and UhpT [20]) have been connected to fosfomy-
cin resistance, their exact contribution to resistance in S. aureus
depends on transport of the drug rather than direct inactivation of
FosB.
The role of BSH in S. aureus clinical isolates has not been pre-
viously examined; therefore, we undertook the current study to
decipher the role of BSH in several methicillin-resistant S. aureus
(MRSA) isolates. Furthermore, the function of FosB outside anti-
biotic resistance has not been ascertained. We report here on the
role of BSH in the oxidative stress response of MRSA, as well as
identify a novel role for FosB in the oxidative stress response.
Collectively, our data suggest that BSH and FosB are crucial for the
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survival of S. aureus when encountering oxidative stresses. In par-
ticular, BSH is required for improved bacterial survival after ex-
posure to professional macrophages and neutrophils, and this ef-
fect is independent of staphyloxanthin production.
MATERIALS AND METHODS
Bacterial strains and culture conditions. The wild-type and mutant S.
aureus strains as well as the plasmids used in this study are listed in Table
1. All S. aureus precultures were grown in tryptic soy broth (TSB;
Teknova) at 37°C with shaking. After overnight growth, the precultures
were diluted to an optical density at 650 nm (OD650) of 0.1 in 5 ml of fresh
TSB, as measured by a Spectronic 20D spectrophotometer (Spectronic
Inc.), using 18-mm borosilicate glass tubes. Escherichia coli strains DH5
and DC10B (21) were grown at 37°C in Luria-Bertani (LB) broth or on LB
agar (Becton, Dickinson). When needed for selection, antibiotics were
used at the following final concentrations: 100g/ml of ampicillin (Amp)
for E. coli and 10 g/ml of chloramphenicol (Cm) for S. aureus.
DNA manipulations. A QIAprep Spin Miniprep kit (Qiagen) was
used to prepare plasmid DNA from E. coli. Plasmid DNA from S. aureus
was isolated by lysostaphin digestion, followed by plasmid extraction with
the QIAprep kit (Qiagen). Chemically competent DH5 or DC10B (21)
strains of E. coli or electrocompetent S. aureus cells were used for trans-
formations. The restriction enzymes, ligases, and molecular weight mark-
ers used in this study were purchased from New England BioLabs. An
Invitrogen TOPO TA cloning kit with pCR2.1 was used in an intermediate
step in the construction of plasmids pALC6572, pALC6574, and
pALC7576 (Table 1) following the manufacturer’s instructions. For the
construction of pALC7246 and pALC7266, a Gateway BP Clonase II en-
zyme mix kit (Life Technologies) was used to introduce the DNA frag-
ments of choice into pKOR1 (22). ExTaq DNA polymerase (Takara) was
used to amplify DNA fragments for all constructs. DNA sequencing was
performed using fluorescently labeled dideoxynucleotide sequencing
(BigDye terminators; PE Applied Biosystems) at the Dartmouth College
Molecular Biology and Proteomics Core Facility.
Constructionof fosB andbshAdeletionmutants and complemented
strains. The fosB mutants in various S. aureus strains—COL, Mu50,
USA300 TCH959, USA300 WI-2335, and the USA300 CDC reference
strain—were generated by in-frame deletion of fosB (sa2124) via allelic
replacement using published protocols for the temperature-sensitive
plasmid pMAD-Cm (23). The primers used for the construction of the
TABLE 1 Strains and plasmids
Strain or plasmid Descriptiona Reference or source
Strains
RN4220 MSSA cloning intermediate derived from 8325-4 60
USA300 CDC CA-MRSA, wild-type reference strain 61
ALC7450 USA300 CDC fosB mutant This study
ALC7574 USA300 CDC fosB mutant complemented with pALC7576 This study
WI-2335 USA300 CA-MRSA, clinical isolate, spa type t008 Sanjay Shukla
ALC6573 WI-2335 fosB mutant This study
ALC6575 WI-2335 fosB mutant complemented with pALC6574 This study
ALC7578 WI-2335 fosB mutant complemented with pALC7576 This study
ALC7262 WI-2335 bshA mutant This study
ALC7263 WI-2335 fosB bshA mutant This study
TCH959 USA300 CA-MSSA, clinical isolate 62
ALC7224 TCH959 fosB mutant This study
ALC7579 TCH959 fosB mutant complemented with pALC7576 This study
COL Archaic HA-MRSA strain 63
ALC7069 COL fosB mutant This study
ALC7070 COL fosB mutant complemented with pALC6574 This study
ALC7071 COL fosB mutant complemented with pALC7576 This study
ALC7247 COL bshA mutant This study
ALC7267 COL bshA mutant complemented with pALC7266 This study
Mu50 VISA 64
ALC7441 Mu50 fosB mutant This study
ALC7506 Mu50 fosB mutant complemented with pALC6574 This study
ALC7432 Mu50 bshA mutant This study
ALC7568 Mu50 bshA mutant complemented with pALC7266 This study
SH1000 MSSA derivative of 8325-4 with a functional rsbU 65
ALC7446 SH1000 with bshC repaired This study
Plasmids
pMAD-Cm Allelic replacement vector containing Cm resistance marker 23
pEPSA5 S. aureus-E. coli shuttle vector with a xylose-inducible promoter 24
pKOR1 Allelic replacement vector containing Cm resistance marker and secY counterselection 22
pALC6572 pMAD-Cm for deletion of fosB This study
pALC6574 pMAD-Cm for the complementation of the fosB deletion This study
pALC7576 pEPSA5 vector for fosB expression This study
pALC7246 pKOR1 for deletion of bshA This study
pALC7266 pKOR1 for the complementation of the bshA deletion This study
pALC7588 pEPSA5 vector for bshA expression This study
pALC7561 pKOR1 for the repair of bshC in the 8325 lineage This study
a CA, community acquired; HA, hospital acquired; MRSA, methicillin-resistant S. aureus; MSSA, methicillin-sensitive S. aureus; VISA, vancomycin-intermediate S. aureus.
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mutants are available upon request. The chromosomal deletion of fosB in
putative mutants was verified by PCR and DNA sequencing. The mutants
were subsequently complemented by using the same pMAD-Cm system
to reintroduce an intact copy of fosB into the native fosB locus of the
mutants.
We also complemented the fosB mutants in trans. In this case, we
transformed pALC7576, a plasmid consisting of a recombinant pEPSA5
(24) containing a xylose-inducible promoter and the ribosomal binding
site followed by the cognate fosB coding region, into E. coli DC10B, fol-
lowed by electroporation directly into the cognate mutants.
The bshA deletion mutants were generated in several strain back-
grounds through in-frame deletion of bshA (sa1291) using pKOR1, a tem-
perature-sensitive plasmid with a Cm resistance selection marker (22).
Chromosomal deletion of bshAwas verified by PCR and DNA sequencing.
The complemented strains were constructed using the same pKOR1 sys-
tem to reintroduce an intact copy of bshA into the native locus on the
chromosome of the mutants. In trans complementation was done by in-
troducing pALC7588, another plasmid consisting of a pEPSA5 backbone
containing a xylose-inducible promoter, followed by the ribosomal bind-
ing site and the cognate bshA coding region, into the bshA mutants.
Determination of LMWthiol levels.For determination of LMW thiol
levels, cultures were diluted 1:100 from precultures into 130 ml TSB in a
500-ml sidearm flask and grown at 37°C with shaking until they reached
an OD650 of 1.1 (late exponential phase). Cultures were divided into 3
samples of 40 ml each (in separate 300-ml sidearm flasks)—with one
treated with 10 mM H2O2, another treated with 1 mM diamide, and the
third treated with medium alone—and grown for an additional 20 min at
37°C with shaking. Individual cultures were then divided into two sam-
ples, each of which was harvested by centrifugation at 3,200 g at 4°C for
analysis. Intracellular reduced thiols (BSH, Cys, and coenzyme A [CoA]
sulfhydrate [CoASH]) were derivatized, in triplicate, with monobromo-
bimane (mBBr). Samples for disulfide analysis were first treated with N-
ethylmaleimide (NEM), followed by dithiothreitol (DTT) reduction and
labeling with mBBr of reduced thiols and oxidized disulfides (BSSB and
cystine), and were analyzed by fluorescent high-pressure liquid chroma-
tography (HPLC), as previously described (18, 25). However, it is not
possible to accurately quantify CoA disulfide because the DTT treatment
used in the disulfide analysis also cleaves thioesters such as acetyl-CoA
into CoA, resulting in an overestimate of CoA disulfide (26). Standards of
known concentration were used to quantify bimane-derivatized thiols
from cellular samples.
Antibiotic susceptibility assays. The determination of the MICs for
fosfomycin, oxacillin, penicillin G, D-cycloserine, vancomycin, imi-
penem, and bacitracin (Sigma) in a broth microdilution format for vari-
ous S. aureus strains was performed according to the Clinical and Labo-
ratory Standards Institute (CLSI) protocol (27). Xylose was added to a
final concentration of 1% to cultures that contained strains comple-
mented with pALC7576 or pALC7588, as well as to their respective iso-
genic mutant and parental strains. In some experiments, exogenous cys-
teine was added to a final concentration of 500M, a concentration which
was previously shown to rescue cysM mutants in S. aureus (28).
Growth of S. aureus bshA and fosB mutants in the presence of hy-
drogen peroxide. For growth in 10 mM H2O2, a nonlethal concentration
that triggers alteration of gene expression (29), cultures were diluted as
described above in 5 ml TSB, with compounds added in addition to the
H2O2 at the following final concentrations: 4 mM diamide was added
immediately, and 50 mM thiourea was added 5 min later. Hourly readings
of the OD650 were taken to monitor growth.
For overnight stress assays, cultures were diluted as described above in
5 ml TSB and grown in triplicate, with one tube containing 25 mM H2O2,
the other containing 5 mM diamide, and the last tube containing both
compounds at the stated concentrations.
Detoxification ofH2O2 by S. aureus. For assay of the detoxification of
H2O2 by S. aureus, precultures diluted to an OD650 of 0.1 in 10 ml of fresh
TSB were exposed to 10 mM H2O2. Serial samples (1 ml each) were taken
from the culture at the desired time points for analysis. An OxiSelect
hydrogen peroxide assay kit (Cellbio labs) was used to quantify H2O2 in
the culture supernatant following the instructions in the manufacturer’s
insert, after the sample was processed by centrifugation and filtration to
remove any residual bacteria.
Assays for peroxidase activity. Three different assays were utilized to
assess the potential peroxidase activity of FosB. First, 5M S. aureus FosB,
overexpressed and purified as recently described (18), was incubated at
22°C in the presence of 250 M BSH and 0.5 mM MgCl2 in 100 mM
HEPES, pH 7. H2O2 was added to 200 M, and the BSH concentration
was monitored over 15 min by titrating reaction aliquots with 2 mM
5,5=-dithiobis-(2-nitrobenzoic acid) (Ellman’s reagent) in 50 mM sodium
phosphate buffer, pH 7.4, and measuring the absorbance at 412 nm using
an extinction coefficient of 14,150 M1 cm1 (30, 31). Control reactions
included assays without either H2O2 or FosB.
Second, horseradish peroxidase (HRP) was used to monitor the H2O2
concentration in the presence of FosB. The assay mixtures consisted of 1
M FosB, 250 M BSH, 0.5 mM MgCl2, and 100 mM HEPES, pH 7, in a
final volume of 50 l. Reactions were initiated with the addition of 250
M H2O2 and monitored over time by quenching with 450 l of 0.5 mM
tetramethylbenzidine and 0.15 mU HRP in 0.1 M sodium phosphate, pH
7.4. After 5 min, an equal volume of 1 M phosphoric acid was added and
the absorbance was read at 450 nm. The H2O2 concentration was deter-
mined using a standard curve of known H2O2 concentrations. The control
reactions did not include either FosB or BSH.
Third, FosB peroxidase activity was assessed using the FOX1 assay
(32). The reaction mixtures, consisting of 0, 1, or 10 M FosB, 100 mM
HEPES, pH 7, 0.5 mM MgCl2, and 100 M BSH, were initiated with 100
M H2O2 and monitored over 30 min by quenching with the FOX1 assay
reagent (100M xylenol orange, 250M ammonium ferrous sulfate, 100
mM sorbitol, 25 mM H2SO4). After incubation at room temperature for
30 min, the samples were centrifuged to pellet the debris and the absor-
bance of the supernatant was read at 560 nm and compared to a standard
curve of known H2O2 concentrations. The control reactions did not in-
clude either FosB or BSH.
NADP/NADPH quantification. The protocol for the quantification
of NADP/NADPH was conducted using an NADPH/NADP kit from
Biovision Inc. modified for S. aureus. As NADPH can be unstable, the
following steps were carried out as quickly as possible. H2O2 (10 mM) was
added to a 10-ml S. aureus culture at an OD650 of 0.1 as described above.
At the indicated time point, cells were pelleted at 3,220 g at 4°C, washed
with cold sterile phosphate-buffered saline (PBS), resuspended in 400 l
of NADP/NADPH extraction buffer (Biovision Inc.) within 10 min of the
initial pelleting of the culture, and lysed with 0.1 mm glass/silica beads in
a BeadBeater apparatus (BioSpec). The resultant supernatant, obtained by
centrifuging samples at 20,000 g for 15 min at 4°C, was filtered through
a 10-kDa-cutoff filter (Amicon), as suggested by the assay manufacturer,
to remove enzymes which utilize NADPH.
Samples (50 l) were transferred in triplicate to a 96-well plate, fol-
lowed by the addition of 100 l of NADP cycling mix to each well. After
incubation in the dark at room temperature for 5 min and the addition of
10 l of NADPH developer, the plate was shaken for 2 h and the OD450
was measured. The concentration of each well was derived from the stan-
dard curve prepared using standards provided by the manufacturer. The
amounts of NADP and NADPH were normalized to the amount of total
cellular proteins.
Total antioxidant capacity. Diluted precultures were grown as de-
scribed above to an OD650 of 0.7, incubated with or without H2O2 for 20
min, and harvested by pelleting. Cells were washed thrice with ice-cold
PBS and resuspended in 600 l of PBS. Cells were then freeze-thawed
twice before mechanical lysis. The supernatant was harvested after cen-
trifugation at 4°C and 5,000 g for 10 min. The protein concentrations of
the samples (30 l each) were determined using a 660-nm protein assay
kit (Pierce). The remaining portions of the samples were assayed using the
OxiSelect total antioxidant capacity assay kit (Cell Biolabs), with the stan-
Posada et al.
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dard curve constructed following the instructions in the manufacturer’s
insert.
RNA extraction. RNA extractions were carried out as previously de-
scribed (33), with some modifications. In brief, cells were inoculated into
30 ml TSB in 300-ml sidearm flasks (Bellco) and grown to an OD650 of 1.1.
The culture was divided into 2 separate 50-ml tubes, one with TSB con-
taining 1 mM diamide and the other with TSB alone as a control, grown
for an additional 20 min, and centrifuged at 3,220  g and 4°C. The
resulting cell pellets were resuspended in 1 ml of TRIzol reagent (Invitro-
gen) and mechanically lysed using 0.1-mm glass/silica beads in a Bead-
Beater apparatus. The RNA in the aqueous phase was precipitated with
ethanol. The RNA used for the microarray analysis was kept in ethanol
until further processing, while the samples used in quantitative reverse
transcription-PCR (qRT-PCR) were resuspended in 50l of diethylpyro-
carbonate-treated water. The concentration and purity of the total RNA
were determined by measuring the absorbance at 230 nm, 260 nm, and
280 nm using a Nanodrop1000 spectrophotometer (Thermo Fisher).
Microarray analysis. The microarray was manufactured by in situ
synthesis of 15,600 60-base-long oligonucleotide probes (Agilent), se-
lected as previously described (34). The probe set covered multiple ge-
nomes and plasmids, as previously published (35).
Total RNA purified from strain COL and the bshA mutant strains as
described above was treated with DNase using an Ambion DNA-free kit.
The removal of DNA was confirmed by quantitative PCR (Mx3005P;
Agilent) with primers specific for the 16S rRNA gene (36). Five micro-
grams of total S. aureus RNA was then reverse transcribed and labeled by
Cy3-dCTP using SuperScript II reverse transcriptase (Invitrogen) and
purified on QIAquick columns (Qiagen). Cy5-dCTP, in the presence of
the Klenow fragment of DNA polymerase I (Invitrogen), was used to label
genomic DNA from strains used to design the arrays, which were used for
the normalization process (36). Hybridization, washings, and scanning
were performed as previously described (35).
Fluorescence intensities were extracted using Feature Extraction soft-
ware (version 9; Agilent). Local background-subtracted signals were cor-
rected for unequal dye incorporation or an unequal load of the labeled
product. Data from three independent biological experiments were ex-
pressed as log10 ratios and analyzed using GeneSpring software, version
8.0 (Silicon Genetics). The statistical significance of differentially ex-
pressed genes was calculated by analysis of variance (ANOVA) including a
Benjamini and Hochberg false discovery rate correction of 5% (P value
cutoff 0.05) and an arbitrary cutoff of 2.0 for expression ratios.
qRT-PCR analysis. qScript cDNA Supermix (Quanta Biosciences)
was used to reverse transcribe DNase I-treated RNA to yield cDNA. Fol-
lowing the manufacturer’s instructions, PerfeCTa SYBR green FastMix
(Quanta Biosciences) was used to generate standard curves of the cDNA
concentration/crossing point (Cp) for the target genes and the reference
gene, gyrB. We analyzed the expression of the target genes using the dilu-
tion for which the qRT-PCRs had the highest efficiency and reproducibil-
ity. Roche’s LightCycler 480 SW (version 1.5) software was used to analyze
the qRT-PCRs. Control reaction mixtures containing master mix and
primers but no cDNA were also analyzed.
Staphyloxanthin extraction. Staphyloxanthin was extracted from
cultures using a modified version of a previously published protocol (37).
Briefly, S. aureus precultures were diluted to an OD650 of 0.1 in 10 ml of
fresh TSB, grown at 37°C for 72 h in triplicate, centrifuged, and washed in
PBS. Staphyloxanthin was extracted with methanol treatment for 20 min
at 42°C, and the OD450 was determined. Cultures that were induced with
10 mM H2O2 or 1 mM diamide were grown as described above, with the
exception that the oxidants were added at the beginning of incubation and
every 12 h until extraction.
Human whole-blood survival assay. Overnight cultures grown in
TSB were harvested by centrifugation and washed three times with PBS.
Then, 2  105 bacterial cells were placed in 1 ml of fresh whole human
blood containing heparin, and the initial inoculum was determined by
serial dilution. Cultures were rotated at 37°C for 5 h, with aliquots re-
moved hourly, serially diluted in PBS, plated on tryptic soy agar, and
incubated at 37°C overnight. Assays with all samples were performed in
triplicate.
Statistical analysis. Data are expressed as the mean standard devi-
ation. For some assays, an unpaired Student’s t test was used to compare
the wild types to the respective fosB or bshA mutants, with P values of
0.05 considered significant. In the analysis of LMW thiol levels, an
ANOVA of thiol content and thiol ratios was carried out, with post hoc
testing being done if the probability of the null hypothesis being true was
less than 0.1; a P value of	0.05 was considered significant.
Microarray data accession number. The complete microarray data
set has been posted on the Gene Expression Omnibus database (http:
//www.ncbi.nlm.nih.gov/geo/) under accession number GPL11157 for
the platform design and accession number GSE46885 for the original data
set.
RESULTS
FosButilizesBSHas a substrate to confer fosfomycin resistance.
In previous studies, FosB was shown to mediate fosfomycin resis-
tance in S. aureus through the use of BSH to disrupt the epoxide
ring of fosfomycin (18, 19, 38). We investigated here the role of
BSH in fosfomycin resistance mediated by FosB in a wide variety
of methicillin-sensitive and methicillin-resistant S. aureus strains,
including clinical isolates. Mutants with clean gene deletions,
complemented mutants, and wild-type strains were used for this
purpose. As expected from previous reports, the fosB mutants of
USA300 CDC, USA300 WI-2335, USA300 TCH959, COL, and
Mu50 all had a fosfomycin MIC of 39.1 g/ml, whereas each cor-
responding wild-type strain exhibited significantly higher fosfo-
mycin resistance levels (Table 2). Complementation of fosB in the
mutants restored the level of fosfomycin resistance to wild-type
levels.
Importantly, the bshA mutation also affects fosfomycin resis-
tance. The deletion of bshA alone and also that of bshA and fosB
together led to the same MIC (39.1 g/ml) as that for the corre-
sponding isogenic fosB mutants. Complementation of bshA in the

bshA strains restored wild-type levels of fosfomycin resistance.
Cysteine (Cys) has been suggested to be a possible substrate for
FosB (19); therefore, we also tested the ability of Cys to restore
fosfomycin resistance in bshA mutants. The addition of 500 M
Cys to the culture medium did not increase the fosfomycin resis-
tance of the bshAmutants (Table 2). The laboratory strain SH1000
contains an intact fosB gene but does not produce BSH due to a
missense mutation in the bshC coding region (13, 14). Following
repair of the bshC gene in SH1000 to yield strain ALC7446, in-
creased fosfomycin resistance was seen in ALC7446 compared to
that seen in isogenic strain SH1000 (625 g/ml versus 9.3 g/ml,
respectively) (Table 2). In S. aureus, the resistance mechanism by
which FosB inactivates fosfomycin appears to require BSH, in line
with detailed kinetic analysis of S. aureus FosB (17, 18).
BSH levels among S. aureus strains. The amount of variance
in fosfomycin MICs (Table 2) among wild-type S. aureus strains
was of interest. One plausible explanation for the heterogeneity in
the MICs of fosfomycin is that each strain may produce a different
amount of BSH. To address this possibility, we quantified the
levels of reduced thiols (BSH, Cys, and CoASH) and oxidized thiol
(BSSB and cystine) in various clinical and laboratory isolates via
HPLC analysis. The data confirmed that ALC7446 produces 0.51
mol BSH per gram of cell dry mass (Table 3). Some variations in
the reduced thiol (BSH, Cys, and CoASH) levels were observed
among the strains. Cys and CoASH levels were not significantly
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different among the strains. The average level of BSH in the COL
and WI-2335 strains was significantly above the average value
among the strains tested, while that of Mu50 was below (Table 3).
The variations in reduced thiol levels did not translate into differ-
ences in the ratios of the level of the reduced thiol to that of its
oxidized form, as these were comparable among the strains (Table
3). Overall, with the exception of SH1000, the levels of BSH
among the strains did not appear to correlate significantly with the
observed levels of fosfomycin resistance.
Mutation of fosB in WI-2335 was accompanied by a 63% re-
duction in BSH levels (P 0.0128), a 48% decrease in Cys levels
(P 0.0142), and a 15% decrease in CoASH levels relative to the
corresponding levels in the parental strain (Table 3). These de-
creases suggest that the absence of FosB affects the redox state of
the cell. However, the BSSB and cystine levels did not change
significantly in the mutant compared to the wild type (data not
shown), showing that the LMW thiol pool in the fosB mutant is
not overly oxidized. The reason for the decreases in the thiol pool
remains unclear and requires further investigations.
Growth of the bshA and fosB mutants under different labo-
ratory conditions. The role of BSH and of FosB in the physiology
of S. aureus has not been well examined. The effect of the bshA and
fosB deletions on the growth rate was determined under a variety
of conditions. To focus our study, we chose to explore the effects
of these mutations on strains COL and WI-2235 because these
strains represent archaic and more recent MRSA isolates, respec-
tively. When grown at 25°C, 37°C, or 42°C, the growth rates of the
mutants did not differ significantly from those of the wild-type
strains. Mutations of bshA and fosB also had no effect on the ob-
served MIC values for several cell wall-active antibiotics, including
oxacillin, penicillin G, D-cycloserine, vancomycin, imipenem, and
bacitracin.
Growth delay of the bshA and fosB mutants after oxidative
stress. Given the reported role of related LMW thiols, such as
GSH, in the protection of cells from oxidative stress (6, 39, 40), we
evaluated the growth of strains USA300 WI-2335 and COL, their
isogenic bshA and fosB mutants, and complemented mutant
strains in the presence of 10 mM H2O2 (Fig. 1). Both the bshA and
fosBmutants of COL and WI-2335 exhibited a growth delay for up
to 4 h when grown in medium containing H2O2 compared to the
growth of the isogenic parent and complemented mutants. To
determine if this delay was due to oxidative stress caused by H2O2,
50 mM thiourea, a scavenger for superoxide radicals, hydroxyl
radicals, and H2O2 (41), was added to the cultures 5 min after
H2O2 treatment. The addition of thiourea to the medium restored
the growth of the fosB and bshA mutants of WI-2335 and COL to
the respective wild-type levels, confirming that the observed
growth delay was due to oxidative stress (Fig. 1, solid lines). These
data also highlight differences that can occur across S. aureus
strains. For example, wild-type COL appears to be more suscep-
tible to the effects of 10 mM H2O2 than wild-type WI-2335 in the
time frame tested (Fig. 1).
Response of fosBmutants to H2O2. While the defect observed
in the bshA mutant grown in TSB with 10 mM H2O2 was expected
(42), the linkage of FosB to the S. aureus oxidative stress response
was not anticipated. To explore whether the observed growth de-
lay of the fosB mutant in response to H2O2 was attributable to the
decreased ability of the mutant to degrade H2O2, the degradation
of H2O2 was assayed in WI-2335 (chosen for its high BSH con-
tent), its isogenic fosBmutant, and the complemented strain. After
10 min, all the strains had degraded approximately 50% of the
exogenously added H2O2, showing no difference in the ability of
the fosB mutant and the parental strain to rapidly degrade H2O2.
At 20 min after the addition of 10 mM H2O2, the concentrations of
H2O2 in the cultures fell to 77.3 9.15 M, 24.4 3.6 M, and
37.6 13.1M for the wild-type strain WI-2335, its isogenic fosB
mutant, and the complemented mutant, respectively, indicating
that all strains were able to degrade more than 99% of the added
TABLE 2 Fosfomycin susceptibility of S. aureus strains and isogenic
mutants
Straina MIC (g/ml)
USA300 CDC 625
ALC7450 (
fosB) 39.1
ALC7574 (
fosB/pEPSA5::fosB) 625
WI-2335 1,250
ALC6573 (
fosB) 39.1
ALC6575 (
fosB::fosB) 1,250
ALC7578 (
fosB/pEPSA5::fosB) 1,250
ALC7262 (
bshA) 39.1
ALC7262 (
bshA) 500 M Cys 39.1
ALC7263 (
fosB 
bshA) 39.1
TCH959 625
ALC7224 (
fosB) 39.1
ALC7579 (
fosB/pEPSA5::fosB) 625
COL 312.5
ALC7069 (
fosB) 39.1
ALC7070 (
fosB::fosB) 625
ALC7071 (
fosB/pEPSA5::fosB) 625
ALC7247 (
bshA) 39.1
ALC7247 (
bshA) 500 M Cys 39.1
ALC7267 (
bshA::bshA) 625
Mu50 2,500
ALC7441 (
fosB) 39.1
ALC7506 (
fosB::fosB) 2,500
ALC7432 (
bshA) 39.1
ALC7432 (
bshA) 500 M Cys 39.1
ALC7568 (
bshA::bshA) 2,500
SH1000 19.3
ALC7446 (BSH positive) 625
a Isogenic strains with the respective mutations are indicated under the parental strain
name.
TABLE 3 Quantification of thiols in select S. aureus strains
Strain
Amt (mol/g)a Ratio
BSH Cys CoASH BSH/BSSB Cys/Cystine
COL 1.07* 0.2 1.08 0.4 0.89 0.50 20.7 16.3 23.6 18.6
Mu50 0.18 0 0.88 0.1 0.42 0.08 26.0 15.0 22.5 9.7
MW2 0.50 0 1.00 0.1 0.69 0.08 18.0 8.7 34.6 17.4
N315 0.45 0.2 1.03 0.2 0.30 0.08 19.2 6.6 59.1 21.0
SH1000 0* 0.0 0.5 0.0 0.59 0.25 0* 0.0 80.8* 30.1
ALC7446 0.51 0.1 1.23 0.3 0.38 0.19 28.0 4.3 51.3 23.4
USA300 LAC 0.42 0.12 1.15 0.3 0.47 0.28 14.9 8.2 35.8 17.3
USA300
WI-2335
1.63* 0.4 1.51 0.1 0.40 0.13 39.4 13.4 19.5 5.0
WI-2335 
fosB 0.61 0.1 0.79 0.0 0.34 0.15 17.4 3.7 12.8 2.5
a mol thiol per g of cell dry mass. *, a significant difference of individual values from
the mean of the entire column group using ANOVA post hoc testing, where P is	0.05.
Due to the zero BSH value of SH1000, this value was not included in the calculation of
the group mean.
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H2O2 within 20 min. This result indicates that the mutant and the
parent had a similar ability to degrade H2O2.
Although the decomposition of H2O2 by S. aureus is largely
attributed to catalase activity (43, 44), there still remains a ques-
tion as to whether a small amount of H2O2 degradation can be
catalyzed by a peroxidase. For example, GSH-S-transferases ex-
hibit peroxidase activity (45, 46), thus alerting us to consider FosB
to be a BSH-dependent peroxidase in S. aureus. However, over the
course of three independent peroxidase assays, purified FosB was
not found to catalyze the degradation of H2O2 in vitro. Therefore,
the role of FosB in protecting S. aureus from oxidative stress does
not appear to involve peroxidative ability.
A third explanation for the observed growth delay is that the
fosB mutants might be more susceptible to killing by H2O2. Via-
bility after an initial encounter with H2O2 was assessed by deter-
mining the number of CFU in a culture immediately before and
after the addition of 10 mM H2O2. Comparisons of the numbers
of CFU revealed comparable killing of the cultures at 45%, 52%,
and 55% for the wild type, the 
fosB strain, and the comple-
mented mutant, respectively, upon exposure to 10 mM H2O2. The
cause of the growth deficiency observed in the fosB mutant after
encountering H2O2 is unknown, but the growth deficiency does
not appear to be caused by the inability of the mutant to degrade
H2O2 or survive exposure to H2O2.
Effects of combined H2O2 and diamide stress. To assess if
thiol stress might play a role in the growth delay observed in the
bshA and fosB mutants of COL and WI-2335 exposed to H2O2,
experiments that combined the thiol oxidant diamide and H2O2
were conducted. The growth defect of the mutants obtained in the
first 4 h with H2O2 could be recapitulated in both the wild type and
complemented strains of WI-2335 and COL by adding 4 mM di-
amide to the culture medium containing H2O2 (Fig. 2). Notably,
strains grown in the presence of 4 mM diamide alone grew at a rate
similar to that for strains grown without diamide.
The effects of both H2O2 and diamide on overnight growth
were also examined to establish if this combined thiol and oxida-
tive stress could affect the growth of the bshA and fosB mutants
over a long period. The combination of 25 mM H2O2 and 5 mM
diamide severely disrupted the overnight growth of the fosB and
bshA mutants of COL and WI-2335, while the wild type and the
complemented mutants of both strains could grow in the presence
of this combination (Fig. 3). Only the bshA mutant of COL had
impaired growth in 5 mM diamide alone (Fig. 3A). In the presence
of 25 mM H2O2, the bshA mutant of WI-2335 failed to grow over-
night (Fig. 3B). These differences in growth again highlight strain-
specific differences which affect the ability of the fosB and bshA
mutants to respond to H2O2 and diamide during overnight
growth.
NADPH levels in the mutant strains. In Gram-negative bac-
teria, oxidative stress has been shown to affect the cellular NADPH
levels (47), as NADPH-dependent disulfide reductases reduce ox-
idized GSH (48, 49). There are four putative oxidoreductases
(YpdA, YqiW, YphP, and YtxJ) that have been postulated to re-
duce oxidized BSH (BSSB) (10, 11, 38). Given the presence of
these genes in S. aureus (e.g., a ypdA homolog [GenBank accession
number YP_008485371]), we explored whether mutation of fosB
or bshA led to changes in NADPH levels in the mutants relative to
the wild type. In TSB and TSB supplemented with 10 mM H2O2,
wild-type COL and complemented mutants had larger amounts
of NADPH than the isogenic fosB or bshA mutants (Fig. 4). In fosB
FIG 1 Growth of isogenic strains in TSB with 10 mM H2O2. Overnight cultures were diluted to an OD650 of 0.1 before the addition of 10 mM H2O2. The growth
of wild-type strains WI-2335 (A and B) and COL (C and D) as well as the isogenic bshA (A and C) and fosB (B and D) mutants and complemented strains in the
medium was monitored via hourly reading of the OD650. Solid lines, the presence of 50 mM thiourea.
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and bshA mutants of COL, there was no measurable NAPDH de-
tected in samples obtained from bacteria grown in TSB (Fig. 4A)
or in TSB with 10 mM H2O2 (Fig. 4B). The fosB and bshA mutants
of COL also had significantly higher levels of NADP than the
wild type in TSB (Fig. 4A).
NADPH levels were also examined in strain WI-2335 and its
isogenic mutants. Unlike COL, however, we were able to comple-
ment the bshA mutant of WI-2335 in trans only with a multicopy
plasmid, as complementation at the chromosomal level was un-
successful. Accordingly, NADPH levels in the complemented
strain are not presented due to magnified results as a result of
elevated induction from a multicopy plasmid. The level of
NADPH in the WI-2335 fosB mutant was 35% of that of the pa-
rental strain in TSB and 1% of that of the wild type in 10 mM H2O2
(P 	 0.0001). The WI-2335 bshA mutant did not have any mea-
surable NADPH, like the COL bshA mutant. In TSB alone, the
WI-2335 parental strain contained 77% less NADP than the iso-
genic fosB mutant (P  0.0004) and 35% less than the bshA mu-
tant (P 0.0007). Together, these results reveal that both mutants
FIG 2 Effect of diamide on growth in H2O2-stressed cells. The growth of
cultures of strains WI-2335 (A) and COL (B) with 10 mM H2O2 and with 4
mM diamide (gray, dashed lines) or without 4 mM diamide (black, solid lines)
was determined at 1-h intervals.
FIG 3 Overnight growth of isogenic strains under oxidizing conditions. Wild-type strains COL (A) and WI-2335 (B) as well as their isogenic fosB and bshA
mutants and complemented mutant strains were diluted to an OD650 of 0.1 in TSB before the addition of 5 mM diamide, 10 mM H2O2, or both compounds and
grown at 37°C for 24 h.
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FIG 4 Relative levels of NADPH in isogenic COL strains. Strains were diluted
to an OD650 of 0.1 in TSB (A) or TSB with 10 mM H2O2 (B) and grown for 4 h
before NADP and NADPH levels per g of total cellular protein were deter-
mined; values were normalized to those for the wild type under the same
conditions. Statistics were calculated relative to the results for the wild type
under the same conditions. *, P	 0.05; **, P	 0.001.
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have lower NADPH levels than the parent, suggesting a reduced
redox capacity due to a relative paucity of the NADPH needed to
reduce oxidized thiols in the fosB and bshA mutants in COL and
WI-2335.
Total antioxidant capacity of isogenic fosB and bshA strains.
The lower levels of NADPH in the fosB and bshA mutants high-
light the possibility that the mutants may have a diminished ca-
pacity to reduce oxidants. The total antioxidant capacity, which is
proportional to copper-reducing equivalents and can be deter-
mined by the ability of the sample to maintain reduced Cu2 (see
Material and Methods), was assayed in the fosB and bshA mutants
as well as their isogenic wild-type and complemented strains. The
mutants displayed a lower antioxidant capacity than the wild type
and the complemented mutant strains (Fig. 5). This reduced ca-
pacity also occurred in the presence of H2O2 (Fig. 5). Further-
more, the bshA and fosB mutants exhibited a lower antioxidant
capacity when grown with H2O2 than without, indicating that the
oxidative stress imposed by H2O2 further reduced the total anti-
oxidant capacity of the mutants (Fig. 5).
Microarray analysis of gene expression in the COL bshAmu-
tant. To understand the global transcriptional changes associated
with the absence of BSH in S. aureus, microarray analyses were
performed with wild-type COL and its isogenic bshA mutant in
TSB with and without diamide at a concentration (1 mM) previ-
ously shown to induce BSH synthesis in Bacillus subtilis (11). We
found that 5% of the genome in the bshA mutant was either up- or
downregulated compared with the level of expression of the iso-
genic parent in TSB (Table 4). The absence of bshA alone had only
a modest effect on the transcriptional response of S. aureus to
diamide.
As expected, in the bshA mutant grown in TSB, bshA was not
expressed (Table 4). The expression of bshB2, the second enzyme
of the BSH biosynthetic pathway, was also decreased in the bshA
mutant in comparison to the level of expression in the parent
(Table 4). The effect of thiol stress (i.e., diamide) on the BSH
biosynthetic genes was also examined in the wild-type strain COL,
showing an increase in the expression of both bshA and bshC, the
third and final gene of the BSH biosynthetic pathway in the pa-
rental strain, in the presence of 1 mM diamide (Table 5; see Table
S1 in the supplemental material). The results were confirmed by
independent qRT-PCR analysis, showing that bshA was upregu-
lated 2.31-fold and bshC was upregulated 5.2-fold in COL cells
treated with diamide compared to the level of regulation in those
grown in TSB alone.
Before the discovery of BSH, CoASH was believed to be the
major LMW thiol in S. aureus (50). Expression of the panBCD
genes, which encode part of the pantothenate pathway that can
lead to CoASH synthesis, was increased almost 3-fold in COL
treated with diamide relative to that in the wild type in TSB (Table
5). In contrast to the increased panBCD expression in COL treated
with diamide, both BSH (0.39 0.15) and CoASH (0.11 0.06)
levels were lower in COL cells treated with diamide than those
grown in TSB alone (Table 3). Just as BSH was found to directly
reduce H2O2 in our peroxidase assays (data not shown), BSH and
CoASH may be acting directly on the diamide, thus causing a
decrease in thiol levels relative to those in the same strain grown in
TSB, despite increases in expression of the respective biosynthetic
genes.
The crtMNQ genes encode part of the biosynthetic pathway for
staphyloxanthin, a virulence factor which has been linked to oxi-
dative stress protection in S. aureus (37). Of particular interest was
the observation that crtMNQ transcription was downregulated at
least 3.5-fold in the COL strain exposed to diamide compared with
the level of expression in the nontreated control (Table 5; see
Table S1 in the supplemental material). The expression of crtM,
the first gene of the staphyloxanthin operon, was also 2.84-fold
lower in COL cells treated with diamide than those not treated
with diamide. Independent qRT-PCR analyses confirmed this de-
crease in crtM transcript levels in diamide-treated cells. The ex-
pression of crtM in the bshA mutant treated with diamide relative
to that in the bshA mutant grown in TSB alone was increased
2.41-fold. Importantly, under diamide induction, the crtM, crtN,
and crtQ transcripts were upregulated 2.63-, 2.08-, and 2.5-fold,
respectively, in the bshA mutant compared to the level of expres-
sion in the parent. The upregulation of crtM in the bshA mutant
under diamide induction was confirmed by qRT-PCR to be 1.5
times higher than the level of expression in the wild type. This
difference in expression of staphyloxanthin biosynthetic genes be-
tween the bshA mutant and the wild type was not seen when com-
paring the wild type and the bshA mutant in TSB alone (Table 4).
Studies have suggested that the operon containing crtMNQ may
be partially regulated by the small RNA ssrA (51); accordingly, we
determined the relative transcript levels of ssrA in our isogenic
strains by qRT-PCR, as ssrA was not part of the probe set in the
microarray. No differences in relative transcript levels of ssrAwere
observed when comparing the transcript levels of COL to those of
the isogenic bshA mutant grown with and without diamide. Sim-
ilarly, there were no differences in relative transcript levels of ssrA
in either strain grown with or without diamide.
Staphyloxanthin levels in isogenic strains. To determine if
FIG 5 Total antioxidant capacity in COL and WI-2335 isogenic strains. The
total antioxidant capacity for isogenic strains of WI-2335 (A) and COL (B),
including their isogenic bshA and fosB mutants, was determined for cultures
grown to an OD650 of 0.7 and induced for an extra 20 min with and without
H2O2. The copper-reducing equivalent of each strain was determined and
normalized as a percentage of the antioxidant capacity of the wild-type strain.
P values were calculated relative to the values for the wild type under the same
conditions. *, P	 0.05; **, P	 0.001.
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TABLE 4 Genes differentially expressed in 
bshA COL strains in TSBa
Gene functional group and gene/locus Function Fold change in expressionb
Transporters
brnQ1 Branched-chain amino acid transport system II carrier 2.14
cbiO Cobalt transporter ATP-binding subunit 2.30
citM Citrate transporter 3.66
copA Copper-transporting ATPase 2.70
cycA-aapA D-Serine/D-alanine/glycine transporter 2.09
feoA Ferrous iron transport protein A 5.00
feoB Ferrous iron transport protein B 3.33
fhuA Ferrichrome transport ATP-binding protein 2.07
fhuB Ferrichrome transport permease protein 2.17
ribU Riboflavin transporter 2.04
SACOL0665 Iron compound-binding ABC transporter, putative 2.90
SACOL1367 Amino acid permease 2.66
SACOL2521 MFS transporter family member, putative 2.19
sirA Iron compound ABC transporter 3.10
uhpT Hexose phosphate transport protein 20.00
Amino acid metabolism and biosynthesis
arcB2 Ornithine carbamoyltransferase 11.11
argG Argininosuccinate synthase 2.63
femC Glutamine synthetase 2.99
glmS Glucosamine:fructose-6-phosphate aminotransferase 2.18
glnA Glutamine synthetase 2.89
glnR Glutamine synthetase repressor 3.60
ipdC Indole-3-pyruvate decarboxylase 2.04
purB Adenylosuccinate lyase 2.13
putA Proline dehydrogenase 4.17
SACOL1058 Class 1 aminotransferase involved in lysine biosynthesis 2.02
SACOL1801 Dipeptidase involved in lysine biosynthesis 2.05
SACOL1976 Nitric oxide synthase, oxygenase subunit 2.13
Carbohydrate metabolism and TCA cycle
gutB Sorbitol dehydrogenase 2.44
lacG 6-Phospho-beta-galactosidase 2.46
ldh1 L-Lactate dehydrogenase 2.38
manA Mannose-6-phosphate isomerase 2.02
pckA Phosphoenolpyruvate carboxykinase 2.33
pflA Formate acetyltransferase 12.50
pflB Formate acetyltransferase 16.67
SACOL0235 Hexitol dehydrogenase 2.10
Virulence factors
agrB Accessory gene regulator protein B 4.76
cidA Holin-like protein 2.08
coa Staphylocoagulase precursor 2.86
ebh Cell wall-associated fibronectin-binding protein 4.78
hla Alpha-hemolysin precursor 2.17
isdA LPXTG cell wall surface anchor protein 2.87
isdC Iron-regulated cell surface protein 2.35
lipA Lipase/esterase 2.45
mntC Iron-repressed lipoprotein 2.08
sarX Regulator of agr and exoprotein synthesis 2.18
sdrC Ser-Asp-rich fibrinogen-binding protein 3.70
spa Protein A precursor 4.17
ssaA Secretory antigen precursor 2.32
Transcriptional regulators
nirR Transcriptional regulator 2.50
SACOL0218 MarR family member 3.85
SACOL1296 GntR family transcriptional regulator 3.95
SACOL2349 TetR family transcriptional regulator 2.08
SACOL2732 Transcriptional regulator, putative 2.00
(Continued on following page)
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TABLE 4 (Continued)
Gene functional group and gene/locus Function Fold change in expressionb
Other
acpD FMN-dependent NADH azoreductase 2.50
bshA Glycosyltransferase involved in BSH biosynthesis 135.15
bshB2 Deacetylase involved in BSH biosynthesis 2.02
clpB ATP-dependent protease 2.56
cmk Cytidylate kinase 2.10
coaBC Phosphopantothenoylcysteine decarboxylase 2.39
cspB Cold shock protein 3.42
cydA Cytochrome d ubiquinol oxidase, subunit I 2.13
gatC Aspartyl/glutamyl-tRNA amidotransferase subunit C 2.73
glpK Glycerol kinase 2.11
greA Transcription elongation factor 2.01
lytH N-Acetylmuramoyl-L-alanine amidase 20.99
mnmA tRNA-specific 2-thiouridylase 2.36
murI Glutamate racemase 2.51
nanA N-Acetylneuraminate lyase 2.38
nuc Thermonuclease precursor 2.68
pepF Oligoendopeptidase F 3.70
pnbA para-Nitrobenzyl esterase 2.50
prmA Ribosomal protein L11 methyltransferase 2.08
queC ExsB protein 2.78
queD 6-Pyruvoyl tetrahydrobiopterin synthase 2.78
queE Radical-activating enzyme 3.13
SACOL0107 Pyridoxal-dependent decarboxylase 2.03
SACOL2121 Acetyltransferase 2.00
sodM Manganese/iron superoxide dismutase 4.55
tagA Teichoic acid biosynthesis protein 2.78
treP PTS system, IIBC components 2.17
ung Uracil-DNA glycosylase 2.11
Hypothetical and putative proteins
SACOL0012 Homoserine O-acetyltransferase, putative 3.77
SACOL0104 LucA family siderophore biosynthesis protein 2.36
SACOL0108 ParBC superfamily member 2.52
SACOL0223 Hypothetical protein 2.44
SACOL0234 Hypothetical protein 2.17
SACOL0303 5=-Nucleotidase 3.53
SACOL0395 Glycine cleavage system H protein, putative 3.23
SACOL0403 BglG family transcriptional antiterminator 2.33
SACOL0411 Membrane-bound protein, putative 2.27
SACOL0449 Lipoprotein, putative 3.57
SACOL0552 RNA-binding protein, putative 2.39
SACOL0568 UvrB/UvrC family member 2.70
SACOL0604 Deoxynucleoside kinase family protein 2.6
SACOL0606 HAD superfamily hydrolase 3.44
SACOL0613 GTP cyclohydrolase, putative 2.31
SACOL0615 Hypothetical protein 2.83
SACOL0625 VraX 2.70
SACOL0632 Hypothetical protein 2.29
SACOL0671 Alpha/beta fold family hydrolase 2.22
SACOL0820 LysM domain-containing protein 2.25
SACOL0939 NifU domain-containing protein 2.10
SACOL1175 Hypothetical protein 2.04
SACOL1226 TM2 domain-containing protein 2.78
SACOL1294 Metallo-beta-lactamase family protein 2.34
SACOL1331 Hypothetical protein 2.19
SACOL1358 Hypothetical protein 2.27
SACOL1359 Hypothetical protein 2.38
SACOL1376 Hypothetical protein 2.13
SACOL1544 Hypothetical protein 2.44
SACOL1548 AtsA/ElaC family protein 2.39
(Continued on following page)
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alterations in the expression of crtMNQ translated into changes in
carotenoid levels, staphyloxanthin was extracted from selected
strains. When cultures were grown in TSB alone, there was no
significant difference in staphyloxanthin production between
COL and its isogenic bshA mutant or WI-2335 and its isogenic
bshA mutant. These experiments were then attempted with H2O2
and diamide treatment, again, without major differences in
staphyloxanthin levels between wild-type strains and the isogenic
mutants being detected.
Given that decreased crtMNQ expression was accompanied by
increased bshA transcription in strain COL treated with diamide,
the effect of overexpression of bshA on staphyloxanthin produc-
tion was explored in wild-type strains SH1000, COL, and WI-
2335. Indeed, overexpression of bshA from a xylose-inducible
multicopy plasmid was accompanied by a decrease in staphy-
loxanthin content in all three wild-type strains relative to that in
the same strain with an empty vector (Fig. 6).
Survival of BSH-deficient strains in a whole-blood assay.
With data supporting the participation of BSH in the oxidative
stress response of S. aureus, we then explored the role of BSH in
the survival of S. aureus strains COL and SH1000 in whole blood
containing neutrophils, macrophages, and complement. In whole
blood, ALC7446 (a BSH-producing strain derived from SH1000)
survived better than wild-type strain SH1000 (Fig. 7A), with a
statistically significant difference in survival in the first hour. For
strain COL, the bshA mutant survived significantly less well than
the parental strain and the complemented mutant at 3 and 4 h
after mixing the bacteria with whole blood (Fig. 7B). These studies
indicate that BSH is important to S. aureus survival in an environ-
ment of oxidative stress in the presence of neutrophils and mac-
rophages.
DISCUSSION
Previous detailed kinetic studies of purified S. aureus FosB have
demonstrated its function as a BSH-S-transferase when detoxify-
ing fosfomycin via conjugation with BSH (18). However, the sig-
nificance of this finding in clinically relevant MRSA isolates has
not been studied. The importance of both BSH and FosB in con-
ferring fosfomycin resistance across several S. aureus strains was
confirmed in this study, as the disruption of fosB and bshA resulted
in at least a 16- to 60-fold reduction in fosfomycin resistance (Ta-
ble 2). The addition of exogenous Cys, a possible FosB substrate,
did not increase the resistance of bshA mutants to fosfomycin,
thus suggesting that FosB does not use Cys to detoxify the cell
well-active antibiotic fosfomycin in the bacteria.
We recognize that the basal MIC of fosfomycin in the fosB and
bshA mutants is relatively high at 39.1 g/ml, despite marked dif-
ferences in resistance in the corresponding parental and comple-
mented strains (Table 2), thus implying that there might be other
factors contributing to basal fosfomycin resistance in S. aureus.
We have examined transporters (e.g., UhpT and GlpT) that may
be involved in the uptake of fosfomycin into cells. There was no
difference in glpT expression in the bshA and fosB mutants versus
the parent. However, the uhpT transcript was upregulated 20-fold
in the bshA mutant versus the level of expression in the parent
(Table 4), but this increase was not found in the fosB mutant (data
not shown). Despite this discrepancy in uhpT levels between the
bshA and fosB mutants, there was no increase in sensitivity to
fosfomycin resistance in the bshA mutant relative to that in the
fosB mutant.
The difference in fosfomycin levels among different MRSA
strains also cannot be explained by divergent BSH levels, as these
levels have no correlation with the levels of fosfomycin resistance
among these strains (Table 3). For example, strain Mu50 had the
highest fosfomycin MIC of the strains tested, but it contained the
second lowest BSH levels, indicating that other factors (e.g.,
the level of FosB or additional transporters) may play a role in the
differences in fosfomycin resistance among S. aureus strains.
Of note, the fold changes in MICs reported here for the bshA
and fosB mutants were higher than those previously reported in
TABLE 4 (Continued)
Gene functional group and gene/locus Function Fold change in expressionb
SACOL1601 Competence protein, putative 2.51
SACOL1670 Hypothetical protein 2.46
SACOL1675 TPR domain-containing protein 2.08
SACOL1788 Hypothetical protein 2.33
SACOL1825 N-Acetylmuramoyl-L-alanine amidase, putative 2.52
SACOL1846 Excalibur calcium-binding domain protein 3.03
SACOL1896 Hypothetical protein 2.53
SACOL2020 Nitroreductase, putative 2.50
SACOL2076 Hypothetical protein 2.94
SACOL2136 NAD/NADP epimerase, putative 2.04
SACOL2163 Hypothetical protein 3.23
SACOL2247 Hypothetical protein 2.63
SACOL2402 S-Transferase, putative 3.45
SACOL2484 Alkylhydroperoxidase, putative 2.94
SACOL2491 Hypothetical protein 3.23
SACOL2528 Hypothetical protein 2.18
SACOL2600 Thioredoxin reductase, putative 2.07
SACOL2676 LPXTG-containing protein 2.33
SACOL2733 Hypothetical protein 2.56
a TCA, trichloroacetic acid; MFS, major facilitator superfamily; FMN, flavin mononucleotide; PTS, phosphotransferase system; HAD, haloacid dehalogenase; TPR, tetratricopeptide
repeat.
b Fold change in expression in COL 
bshA mutants relative to the level of expression in the wild type.
Posada et al.
326 iai.asm.org Infection and Immunity
TABLE 5 Selected genes with altered expression in COL induced with 1 mM diamidea
Gene functional group and gene/locus Function Fold change in expression
Transporters
feoA Ferrous iron transport protein A 2.76
fhuA Ferrichrome transport ATP-binding protein 2.50
fhuB Ferrichrome transport permease 2.61
fhuD Ferrichrome transport permease 3.15
nupC Nucleoside permease 10.83
rarD Superfamily drug/metabolite transporter 4.58
SACOL0261 Putative drug transporter 4.85
sirA Iron compound ABC transporter 3.25
tagH Teichoic acid export protein ATP-binding subunit 3.54
vraD ABC transporter ATP-binding protein 2.99
vraE ABC transporter, permease protein 2.29
Carbohydrate metabolism and TCA cycle
ccpA Catabolite control protein 2.41
panB 3-Methyl-2-oxobutanoate hydroxymethyltransferase 2.70
panC Pantoate-beta-alanine ligase 2.67
panD Aspartate alpha-decarboxylase 2.84
Nucleotide excision and repair
mutS2 Recombination and DNA strand exchange inhibitor protein 2.71
radA DNA repair 4.69
radC DNA repair protein 4.68
SACOL1954 Exonuclease 3.47
uvrA Excinuclease ABC subunit A 2.67
uvrB Excinuclease ABC subunit B 2.97
uvrC Excinuclease ABC subunit C 3.37
Virulence factors
crtM Squalene desaturase 3.50
crtN Squalene synthase 3.87
crtQ Glycosyltransferase 3.65
ebh Cell wall-associated fibronectin-binding protein 5.99
hla Alpha-hemolysin precursor 6.37
mntC Iron-repressed lipoprotein 9.11
SACOL1220 Fibronectin/fibrinogen binding-related protein 3.47
spa Immunoglobulin G binding protein A precursor 3.56
sspA Serine protease 2.28
Transcriptional regulator, spxA Transcriptional regulator 2.33
Other
adaB Methylated DNA-protein cysteine methyltransferase 2.33
atpA FoF1 ATP synthase subunit alpha 3.15
atpB FoF1 ATP synthase subunit A 3.34
atpC FoF1 ATP synthase subunit epsilon 2.43
atpD FoF1 ATP synthase subunit beta 2.62
atpE FoF1 ATP synthase subunit C 2.91
atpF FoF1 ATP synthase subunit B 3.05
atpG FoF1 ATP synthase subunit gamma 2.86
atpH FoF1 ATP synthase subunit delta 2.98
bshA Glycosyltransferase involved in BSH biosynthesis 2.31
bshC BSH synthase 5.20
cinA Competence/damage-inducible protein 2.67
clpB ClpB chaperone-like protein 34.39
clpP ATP-dependent Clp protease, proteolytic subunit 5.35
dnaK Molecular chaperone 7.93
groEL Chaperonin 7.17
groES Cochaperonin 7.25
grpE Heat shock protein 6.76
hslO Hsp33-like chaperonin 3.92
lytH N-Acetylmuramoyl-L-alanine amidase 3.31
(Continued on following page)
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the literature (16- to 60-fold lower as opposed to 4 to 8 times
lower) (18). This discrepancy can be explained by the use of a
nonstandard protocol for MIC assays in the prior study (e.g., the
use of TSB instead of Mueller-Hinton broth, as suggested in the
CLSI protocol [27]). In addition, the previous BSH studies have
utilized transposon mutants (18, 38) constructed in a strain cured
of its plasmids (52); in addition, these studies did not complement
the mutation to exclude any insertional polar effects that may have
been caused by the transposon’s insertion. We have confirmed
here the contribution of both BSH and FosB to fosfomycin resis-
tance in S. aureus using cis and trans complementation of our
mutations.
We then examined whether BSH contributed to the response
of S. aureus to oxidative stress and if FosB had a role in this re-
sponse. Growth studies with 10 mM H2O2 showed a growth delay
of the fosB and bshA mutants, suggesting that both BSH and FosB
may play a role in the cell’s response to oxidative stress. In the
study carried out by Pöther et al. (14), strain 8325-4, a bshC mu-
tant, was found to show equal resistance to 10, 20, and 40 mM
H2O2 as the exogenously complemented, BSH-producing iso-
genic strains, divergent from what we have found in this study. In
that study (14), LB medium was used, while we used TSB here.
Pöther et al. (14) noted that LB medium can quench oxidants
because of the peptides and amino acids present in the medium. In
addition, unpublished work done in the Cheung lab has shown
that the concentration of H2O2 necessary to kill S. aureus is depen-
dent on the amount of cells present. For instance, 10 mM H2O2
can cause a growth delay in cultures of bshA mutants at an OD650
of 0.1 but has no effect on a culture of mutants at an OD650 of 0.5,
presumably due to the various amounts of catalase present. To-
gether, these differences may account for the divergent results on
the effect of H2O2 on S. aureus BSH-deficient cells between our
study and that of Pöther et al. (14).
The cause of the observed growth defect of the fosBmutant was
not an inability to degrade the H2O2. We also established that
purified FosB does not have peroxidase activity. Furthermore, vi-
ability studies indicated that the mutant cells were not killed by
H2O2 but remained in a quiescent state in response to the initial
oxidative stress. This effect of H2O2 on the growth of the bshA and
fosB mutants could be replicated in wild-type cells when the oxi-
dation caused by H2O2 was exacerbated by reversible thiol oxida-
tion caused by diamide (Fig. 2). A recent study on the proteomic
response of S. aureus to several stress conditions argues that S.
aureus has a triphasic response to H2O2: an acute phase, a recovery
phase, and a tolerance phase (53). The recovery phase is charac-
terized by the resumption of growth and the repair of DNA dam-
age. One explanation for the growth delay observed in the fosB and
bshA mutants upon exposure to H2O2 may be related to the in-
creased or sustained oxidation of cellular thiols present in proteins
that are needed for growth during the recovery phase (4).
One function that has previously been attributed to BSH is the
protection of protein thiols upon hypochlorite stress (25, 42). The
results in this study indicate that thiol protection is also part of
the oxidative stress response of S. aureus to H2O2. This protection
may be dependent on FosB. The combined effect of diamide and
H2O2 on the overnight growth of the fosB mutants further sup-
ports the notion that FosB is part of the S. aureus oxidative stress
response. However, it should be noted that just as wild-type S.
aureus showed a range of fosfomycin MICs, the mutation of bshA
had different effects on the sensitivity of wild-type strains COL
and WI-2335 to 25 mM H2O2 and 5 mM diamide, which may be
due to inherent differences in the physiology of the strains.
An abnormal recovery from oxidative stress led to the analysis
of the NADP and NADPH pools in the bshA and fosB mutants as
well as the BSH levels in the fosBmutant. The decreased amount of
measurable NADPH present in both mutants, despite the pres-
ence of higher levels of NADP, suggested that NADPH is being
utilized more quickly in the bshA and fosB mutants (Fig. 4). In the
bshA and fosB mutants, larger amounts of NADPH could be used
as a reducing agent by NADPH-dependent disulfide reductases.
This explanation only partially answers the major question of why
BSH levels are lower in the fosB mutant than in the parent, while
BSSB levels are similar. Increased amounts of NADPH are needed
to reduce BSSB when BSH levels are lower, therefore maintaining
BSSB levels at the level observed in the parental strain and lower
NADPH levels than in the parent. However, why the LMW thiol
TABLE 5 (Continued)
Gene functional group and gene/locus Function Fold change in expression
pbp4 Penicillin-binding protein 4 2.41
recJ Single-stranded-DNA-specific exonuclease 2.52
recX Recombination regulator 2.33
rexA Exonuclease 2.51
sigB RNA polymerase sigma factor SigB 3.29
rsbV Anti-sigma B factor 2.30
rsbW Serine-protein kinase 3.29
zwf Glucose-6-phosphate 1-dehydrogenase 3.38
Hypothetical and putative proteins
SACOL1553 Glyoxalase family protein 2.46
SACOL1749 NADP-dependent malic enzyme, putative 2.20
SACOL1753 Universal stress protein 2.92
SACOL1835 Aldo/keto reductase family oxidoreductase 2.42
SACOL2293 NAD/NADP octopine/nopaline dehydrogenase family 3.21
sarV Hypothetical protein 2.42
tal Transaldolase, putative 4.47
tpx Thiol peroxidase, putative 2.34
a For a complete listing of genes that showed altered expression in this analysis, see Table S1 in the supplemental material. TCA, trichloroacetic acid.
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levels (BSH, Cys, and CoASH) are decreased in the fosB mutant
relative to the WI-2335 wild type remains unknown.
While Upton and coworkers demonstrated in vitro that BSH
inhibits BshA activity (54), they also proposed that the regulation
of BSH biosynthesis might be multifactorial. The microarray
comparing the bshA mutant to parent strain COL showed that in
the absence of BshA, expression of bshB2 is downregulated. This
downregulation suggests that bshB2 is responding to a signal
caused by the mutation of bshA, as bshA and bshB2 are not on the
same operon. The nature of the signal (divergent or shared, direct
or indirect) is unclear and requires further investigation. One of
the possible signals for bsh genes is probably connected to thiol
stress, as diamide, which oxidizes thiols and decreases reduced
thiol levels, increases expression of both bshA and bshC in the wild
type (see Table S1 in the supplemental material). SpxA, which has
been connected to both the diamide stress response (55) and the
regulation of BSH synthesis (56) in B. subtilis, is upregulated in
cells treated with diamide and may be the link connecting the
disparate operons.
Of great interest was the indication that genes involved in the
production of staphyloxanthin, which has been implicated in the
oxidative stress response (37), are expressed differently between
COL and its isogenic bshA mutant when both strains are grown in
diamide. Although the bshA mutant exhibited increased crtM
transcription, we were not able to correlate increased gene expres-
sion to elevated staphyloxanthin production in mutants grown in
TSB alone, H2O2, or diamide. The reasons for this discrepancy are
not clear, but we speculate that the extraction method may not be
as sensitive as the gene expression assay. Alternatively, given the
time frame of growth (72 h) necessary for the production and
extraction of staphyloxanthin, the effect of oxidants may have
dissipated by the time that the staphyloxanthin levels were ana-
lyzed. However, there was an observable decrease in staphyloxan-
thin production when bshA was overexpressed, even in the ab-
sence of BSH, thereby suggesting that an uncharacterized
connection exists between these two factors. This observation was
also of interest because staphyloxanthin has been shown to play a
role in the survival of S. aureus in neutrophils (37, 57).
A previous investigation into the survival of S. aureus strains
SH1000 and 8325-4 (both of which are bshC mutants) expressing
FIG 6 Staphyloxanthin levels in strains SH1000, WI-2335, and COL. Staphy-
loxanthin levels determined at an OD450 were normalized to those determined
at an OD650 in wild-type strains COL (A), WI-2335 (B), and SH1000 (C)
containing pEPSA5 (empty vector) or pALC7588 (pEPSA5 containing bshA)
in TSB with 1% xylose. Statistics were calculated relative to the levels in the
strain with pEPSA5. *, P	 0.05; **, P	 0.0001.
FIG 7 Survival of isogenic strains in a human whole-blood survival assay. The
numbers of CFU of wild-type SH1000 or ALC7446 (SH1000 with a repaired
bshC locus) (A) and the COL wild type, the 
bshA mutant, and the comple-
mented mutant (B) were determined hourly over the course of the human
whole-blood killing assay and were normalized to the initial inoculum. Statis-
tics were calculated relative to the values for the wild type. *, P	 0.05; **, P	
0.001.
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nonphysiological levels of bshC exogenously on a plasmid showed
that BSH in those laboratory strains supported growth in host cells
(14). Here, we demonstrate that the inability to produce BSH
through either the mutation of bshC (SH1000) or the deletion of
bshA (COL) had significant effects on the ability of a strain to
survive in a human whole-blood assay, strengthening the idea that
BSH, and not the individual synthetic enzymes, is supporting the
survival of S. aureus in phagocytes. More importantly, as the mu-
tant possesses the capacity to produce more staphyloxanthin than
the wild type under stress conditions, BSH appears to be playing
an important role in the survival of S. aureus in the host, possibly
independently of staphyloxanthin levels. The bshA and bshC mu-
tants have a diminished capacity to respond to oxidative stress,
such as that generated by professional phagocytes, perhaps ex-
plaining the increased susceptibility of BSH mutants to killing in
the human whole-blood assay. However, the precise role of BSH,
including the contribution of FosB and its newly observed role in
the oxidative stress response, remains ill defined.
Many studies that proposed to identify and characterize major
components in the oxidative stress response of S. aureus used
SH1000 as their model strain (28, 43, 57–59). One consideration
raised by our studies into the role of BSH in the oxidative stress
response is whether the results of studies conducted in SH1000 or
in strains of the 8325 lineage, such as RN6390 and RN4220, which
do not produce BSH, are reflective of the results that would be
obtained with clinical isolates. In light of the fact that BSH con-
tributes to oxidative stress resistance, conclusions based on studies
conducted with strains of this lineage may need to be reexamined.
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